DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Rentiapril
Rentiapril
Supplementary Appendix 1. Search Strategy for the Systematic Review and Meta-Analysis
WO 2017/055924 A2 6 April 2017 (06.04.2017) W P O PCT
Angiotensin-Converting Enzyme (ACE)
Angiotensin Converting Enzyme Inhibitors in the Treatment of Hypertension
Supplementary Appendix 1. Search Strategy for the Systematic Review and Meta-Analysis
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
Wo 2011/060945 A2
Systematic Evidence Review from the Blood Pressure Expert Panel, 2013
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Angiotensin-Converting Enzyme (ACE)
United States Patent (19) 11 Patent Number: 6,139,847 Chobanian Et Al
Telmisartan Versus Angiotension-Converting
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Angiotensin-Converting Enzyme Inhibitor Induced Cough in Chinese Patients: a Systematic Review and Meta-Analysis
(12) United States Patent (10) Patent No.: US 9.446,032 B2 Madhukar Kodgule Et Al
Modern Development in ACE Inhibitors
First-Line Combination Therapy Versus First-Line Monotherapy for Primary Hypertension (Review)
Top View
Angiotensin Converting Enzyme Inhibitors in the Treatment of Hypertension
Angiotensin-Converting Enzyme Inhibitors
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmacotherapy for Hypertension in Adults Aged 18 to 59 Years (Review)
Alacepril a Neuronal Positive Control
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
An Application to Include Blood Pressure Lowering Drug Fixed Dose
Harmonized Tariff Schedule of the United States (2006) (Rev
Supplementary Appendix